Professor Georgina Long hands on baton of SMR Presidency
31 October 2020
MIA’s Co-Medical Director, Professor Georgina Long AO, has passed the baton after two years as President of the Society for Melanoma Research (SMR). The US-based SMR is the world’s largest association of melanoma researchers and scientists. Professor Long was the first Australian and first female President of SMR, her election testament to her international standing as one of the world’s pre-eminent melanoma clinicians and researchers.
The annual 2020 SMR Melanoma Congress, scheduled to be held in New Orleans, was postponed due to the impact of COVID-19. Instead, a Virtual Congress was held during which Professor Long handed over the Presidency to Professor Ashani Weeraratna from Johns Hopkins School of Medicine.
In a message to SMR members, Professor Long said, ‘ The COVID-19 pandemic has presented a major challenge for all of us across the world, and we stand united in limiting the impact of the virus on our health, productivity and goals.’
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
‘Despite not being able to gather in person, as we usually do annually, we connected virtually from around the world to share our knowledge and continue our collaboration,’ Professor Long said. ‘Importantly, we highlighted the work of two fabulous researchers in the field who both received SMR Awards for their contributions – Stefani Spranger was awarded the Young Investigator Award and Yardena Samuels was awarded the Estela Medrano Award.
‘It has been an honour to lead SMR for the past two years, and I look forward to continued collaboration as we move ever closer to reaching our goal of zero deaths from melanoma,’ she said.
Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.
Promising young MIA researcher conferred with University of Sydney PhD.
Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Honouring the exceptional impact of his work on communities around the world.
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
Awarded for their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.